Imaging the dopaminergic system in suspected parkinsonism, drug induced movement disorders, and Lewy body dementia.
This review discusses the role of pre- and post-synaptic dopaminergic imaging in suspected Parkinson's disease, vascular parkinsonism, the parkinsonian syndromes, drug induced movement disorder, and Lewy body dementia. It is envisaged that this information may be useful to neurologists, psychiatrists, physicians/geriatricians, radiologists and nuclear medicine physicians.
Kemp
Paul M
PM
Department of Nuclear Medicine, Southampton University Hospitals NHS Trust, UK. paul.kemp@suht.swest.nhs.uk
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D002986:Clinical Trials as Topic; D018492:Dopamine Antagonists / Q000493:pharmacokinetics; D004409:Dyskinesia, Drug-Induced / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D020961:Lewy Body Disease / Q000000981:diagnostic imaging* / Q000378:metabolism; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000378:metabolism; D010818:Practice Patterns, Physicians'; D011868:Radioisotopes / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*
D018492:Dopamine Antagonists; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2